Cytoflavin

Cytoflavin is a metabolic agent and antioxidant composed of succinic acid, inosine, nicotinamide, and riboflavin. It is designed to stimulate aerobic glycolysis and oxidative phosphorylation, thereby increasing ATP production and improving the energy status of cells, particularly in the central nervous system. Developed by Polysan, it is primarily indicated for the treatment of cerebrovascular diseases, including acute ischemic stroke, chronic cerebral ischemia, and toxic or hypoxic encephalopathy. The drug works by enhancing the utilization of oxygen by tissues and activating antioxidant enzymes, which helps mitigate the effects of oxidative stress and promotes neurological recovery.

Brand names

Cytoflavin

Other names

Цитофлавин